Does VEDOLIZUMAB Cause Hypersensitivity? 771 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 771 reports of Hypersensitivity have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 1.0% of all adverse event reports for VEDOLIZUMAB.
771
Reports of Hypersensitivity with VEDOLIZUMAB
1.0%
of all VEDOLIZUMAB reports
388
Deaths
415
Hospitalizations
How Dangerous Is Hypersensitivity From VEDOLIZUMAB?
Of the 771 reports, 388 (50.3%) resulted in death, 415 (53.8%) required hospitalization, and 301 (39.0%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for VEDOLIZUMAB.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which VEDOLIZUMAB Alternatives Have Lower Hypersensitivity Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB